A clinical study explores whether echocardiography can detect heart amyloid as an early sign of Alzheimer’s, while laboratory research maps a biphasic gene expression cascade in the brain that identifies new therapeutic targets.
The U.S. five-year cancer survival rate reached 70% in 2025, creating 18.6 million survivors. Health systems are expanding survivorship care using advanced practice providers and investing over $4 billion in oncology infrastructure to meet growing demand.
Recent prostate cancer research includes a Phase 2 trial of opaganib in advanced disease, a SEER study linking older age to higher mortality in bone-only metastases, and AI and genetic tools that improve detection.
Tirzepatide, the active ingredient in Mounjaro, reduced alcohol intake by more than half in animal models and prevented relapse-like drinking behaviors, offering potential insights for alcohol use disorder treatment.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07754578 |
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use Pharmacotherapy |
NOT_YET_RECRUITING | PHASE2 |
| NCT07743229 |
COG+OT Telerehabilitation for Adults With Subjective Cognitive Complaints |
NOT_YET_RECRUITING | NA |
| NCT07743190 |
A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) |
RECRUITING | PHASE2 |
| NCT07720180 |
Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab |
NOT_YET_RECRUITING | PHASE2 |
| NCT07720167 |
Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer |
NOT_YET_RECRUITING | PHASE2 |
| NCT07707102 |
Advancing Skills Through Consultation, Education, and Novel Technologies |
RECRUITING | NA |
| NCT07701785 |
Superior Parietal iTBS for PD-MCI |
RECRUITING | NA |
| NCT07697274 |
Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial |
NOT_YET_RECRUITING | EARLY_PHASE1 |
| NCT07689773 |
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label |
RECRUITING | PHASE2 |
| NCT07660887 |
Olfactory Dysfunction in Aging Adults |
NOT_YET_RECRUITING |
